Verified peer comparison
PharmaCyte Biotech vs J-Long Group Financial Comparison
Direct answer
PharmaCyte Biotech and J-Long Group are compared on the same basis.
The comparison uses 2026 results reported in USD.
Common metrics include Revenue, Operating income, Net income, Operating cash flow.
Alpha Vantage
Get free PharmaCyte Biotech email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- PharmaCyte Biotech Revenue
- 0 USD
- J-Long Group Revenue
- 5,411,089 USD
- PharmaCyte Biotech Operating income
- -5,304,286 USD
- J-Long Group Operating income
- 378,840 USD